<strong>Other</strong> <strong>Activities</strong>2DistinguishedVisitors and LecturesName & Address Topic Date1. Dr. Pavan MuttilUniversity of New Mexico, Albuquerque2. Dr. Simi AliNewcastle University, UK3. Dr. S.C. PandeyUniversity of Illinois, USA4. Dr. Kallolmay BiswasUniversity of Edinburgh, UK5. Dr. Shantanu ChakrabortyCincinnati Children's Hospital, USA6. Prof. Peter YorkUniversity of Bradford, UK7. Dr. M.K. RaizadaUniversity of Florida, USA8. Dr. P.N. YadavUniversity of North Carolina, USA9. Dr. Ateeq AhmadJina Pharmaceuticals Inc., USA10. Dr. Rajeev S. MenonAustralian National University, Canberra11. Dr. Martine DefaisCNRS, France12. Dr. Parul TripathiICGEB, New Delhi13. Dr Amit K PandeyUniversity of MassachusettsMedical School, USA14. Dr. Ravi NatarajanKemxtree, Mumbai15. Dr. Denis MartinDNDi, Geneva16. Dr. Kumaravelu JagaveluMayo Clinic, Rochester17. Dr. Susanta KarCSIR-IICB, Kolkata18. Dr. Shreedhara GuptaHeritage <strong>Institute</strong> of Technology, Kolkata19. Dr. Kempaiah RayavaraLaboratory of Malaria andVector <strong>Research</strong>, NIH, USA20. Prof. Tejender S. ThakurIndian <strong>Institute</strong> of Science, Bangalore21. Dr. Subhabrata ChaudhuryUniversity of Glasgow, UKInhaled dry powder for chemotherapy and vaccination 04.01.2011Regulation of chemokine function during inflammation 04.01.2011Epigenetics-beyond the genome in alcoholism 19.01.2011Success in selective catalysis for organic synthesis and developmentof drugs in medicinal chemistry21.01.2011Twistl and Tbx20 function in heart development and disease 25.01.2011Particle engineering for respiratory drug delivery 31.01.2011Angiotensin converting enzyme2 as novel target for cardio-pulmonarytherapeutics08.02.2011Critical role of serotonin and its receptors in antipsychotic drug action 21.02.2011Targeting HER2, ER and endoxifen as a new cornerstone for breastcancer therapyA journey in synthesis: From perhydroazulenes to a gold mine ofheterocyclesBiological science cooperative programme between CNRS and Indiaand Europe25.03.201130.03.201108.04.2011Atherosclerosis: The immunological orchestra 25.04.2011Mycobacterium tuberculosis on steroids 19.05.2011Discovery of a new class of potent, selective and orally efficacious P38MAP Kinase inhibitors for the treatment of Rheumatoid ArthritisDNDi strategies to identify and develop new chemical entities to treatvisceral leishmaniasis23.05.201107.06.2011Protective role of MK2 in atherosclerosis 09.06.2011From cells to signalling cascades: Manipulation of macrophagedefense by leishmania parasitesA new vista towards parasitic protozoans: Leishmania andTrypanosoma14.06.201116.06.2011Functional mechanosensitive ion channel in Plasmodium falciparum 01.07.2011Computational and experimental studies on weak non.bondedinteractionsTowards the total synthesis of potent antifungal agent Gambieric AcidA: Stereo selective preparation of A.D ring fragment27.07.201109.08.201192 CSIR-CDRI
Distinguished Visitors and LecturesName & Address Topic Date22. Dr. Srinivas PentyalaStony Brook Medical Centre, New York23. Prof. Raj KumarThe Commonwealth MedicalCollege, Scranton, USA24. Dr. Yusuf AkhterEuropean Molecular BiologyLaboratory, Hamburg, Germany25. Dr. Senthil DuraisamyG7 Synergon Private Limited, Bangalore26. Dr. S. ChandrasekharCSIR-IICT, Hyderabad27. Prof. Dr. Jörg RademannLeibniz <strong>Research</strong> <strong>Institute</strong> for MolecularPharmacology, Germany28. Dr. Mallikarjun BadadaniUniversity of California Irvine, USA29. Dr. Ajit C. KunwarCSIR-IICT, HyderabadTranslational approach to drug discovery 09.08.2011Structure and functions of the steroid hormone receptors 18.08.2011Molecular and structural studies on targets from MycobacteriumtuberculosisG.Protein coupled receptor (GPCRs) and drug discovery: A historicalperspective25.08.201129.08.2011Total synthesis of marine natural products as pharmaceutical leads 19.09.2011Fragment based protein ligand discovery by dynamic ligation screening 04.11. 2011VCP (p97) functions, diseases and mouse model 2.12.2011Prof. K Rangadhama Rao Memorial Lecture (2011) entitled Peptidic.‘Foldamers’ – Structural Perspectives from NMR5.12.2011Annual Report 2011-12 93